HANS MOEBIUS

Insider Reports History

Location
Seattle, WA
Signature
/s/ Mark Worthington, Attorney-in-Fact for Hans Moebius
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by HANS MOEBIUS:

Company Role Class Num Shares Value Price $ Report Date Ownership
Athira Pharma, Inc. Chief Medical Officer Common Stock 91,482 $266,213 $2.91 04 Jan 2024 Direct
Athira Pharma, Inc. Chief Medical Officer Stock Option (Right to Buy) 0 02 Jun 2023 Direct

Insider Reports Filed by HANS MOEBIUS

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ATHA Athira Pharma, Inc. 04 Jan 2024 1 $0 4 Chief Medical Officer 08 Jan 2024, 16:45
ATHA Athira Pharma, Inc. 02 Jun 2023 3 +$29,352 4 Chief Medical Officer 06 Jun 2023, 19:35
ATHA Athira Pharma, Inc. 19 Jan 2023 1 $0 4 Chief Medical Officer 23 Jan 2023, 16:53
ATHA Athira Pharma, Inc. 15 Nov 2022 1 +$16,442 4 Chief Medical Officer 17 Nov 2022, 18:10
ATHA Athira Pharma, Inc. 13 Oct 2022 2 +$10,639 4 Chief Medical Officer 17 Oct 2022, 18:06
ATHA Athira Pharma, Inc. 28 Jun 2022 1 +$28,800 4 Chief Medical Officer 30 Jun 2022, 17:00
ATHA Athira Pharma, Inc. 22 Jun 2022 2 +$11,995 4 Chief Medical Officer 24 Jun 2022, 19:54
ATHA Athira Pharma, Inc. 18 Jan 2022 2 +$10,371 4 Chief Medical Officer 20 Jan 2022, 16:25
ATHA Athira Pharma, Inc. 21 Jul 2021 5 +$67,997 4 Chief Medical Officer 21 Jul 2021, 16:47